Armstrong-James, Darius
Funding for this research was provided by:
Wellcome Trust (219551/Z/19/Z)
National Institute for Health Research (NIHR200646)
Cystic Fibrosis Trust (SRC 15)
Article History
Received: 15 March 2021
Accepted: 3 July 2021
First Online: 29 September 2021
Declarations
:
: DAJ holds founder share options in Pulmocide Ltd and has received investigator-led grants from Pulmocide Ltd and Gilead Sciences.